Drug Profile
NBI 31199
Alternative Names: NBI-31199Latest Information Update: 01 Mar 2011
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class Anxiolytics; Heterocyclic compounds
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Traumatic stress disorders
Most Recent Events
- 08 Apr 1999 New profile
- 08 Apr 1999 Preclinical development for Stress disorders in USA (Unknown route)